266 related articles for article (PubMed ID: 11929777)
1. Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4.
Basak SK; Harui A; Stolina M; Sharma S; Mitani K; Dubinett SM; Roth MD
Blood; 2002 Apr; 99(8):2869-79. PubMed ID: 11929777
[TBL] [Abstract][Full Text] [Related]
2. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.
Brasel K; De Smedt T; Smith JL; Maliszewski CR
Blood; 2000 Nov; 96(9):3029-39. PubMed ID: 11049981
[TBL] [Abstract][Full Text] [Related]
3. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.
Liu B; Tan W; Barsoum A; Gu X; Chen K; Huang W; Ramsay A; Kolls JK; Schwarzenberger P
Exp Hematol; 2010 Oct; 38(10):877-884.e1. PubMed ID: 20600582
[TBL] [Abstract][Full Text] [Related]
4. GM-CSF expands dendritic cells and their progenitors in mouse liver.
Pillarisetty VG; Miller G; Shah AB; DeMatteo RP
Hepatology; 2003 Mar; 37(3):641-52. PubMed ID: 12601362
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694
[TBL] [Abstract][Full Text] [Related]
6. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.
O'Keeffe M; Hochrein H; Vremec D; Pooley J; Evans R; Woulfe S; Shortman K
Blood; 2002 Mar; 99(6):2122-30. PubMed ID: 11877288
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan Binding Identifies a Functionally Distinct Alveolar Macrophage-like Population in Bone Marrow-Derived Dendritic Cell Cultures.
Poon GF; Dong Y; Marshall KC; Arif A; Deeg CM; Dosanjh M; Johnson P
J Immunol; 2015 Jul; 195(2):632-42. PubMed ID: 26085682
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.
Daro E; Pulendran B; Brasel K; Teepe M; Pettit D; Lynch DH; Vremec D; Robb L; Shortman K; McKenna HJ; Maliszewski CR; Maraskovsky E
J Immunol; 2000 Jul; 165(1):49-58. PubMed ID: 10861034
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of recombinant granulocyte-macrophage colony-stimulating factor and interleukin-3 in murine B-cell leukemia.
Fabian I; Kletter Y; Slavin S
Blood; 1988 Sep; 72(3):913-8. PubMed ID: 3046686
[TBL] [Abstract][Full Text] [Related]
10. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells.
Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A
J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity.
Yokota A; Takeuchi H; Maeda N; Ohoka Y; Kato C; Song SY; Iwata M
Int Immunol; 2009 Apr; 21(4):361-77. PubMed ID: 19190084
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells induced in the presence of GM-CSF and IL-5.
Yi H; Zhang L; Zhen Y; He X; Zhao Y
Cytokine; 2007 Jan; 37(1):35-43. PubMed ID: 17382554
[TBL] [Abstract][Full Text] [Related]
14. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen.
Lu L; Woo J; Rao AS; Li Y; Watkins SC; Qian S; Starzl TE; Demetris AJ; Thomson AW
J Exp Med; 1994 Jun; 179(6):1823-34. PubMed ID: 8195710
[TBL] [Abstract][Full Text] [Related]
15. A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine splenocytes.
Berthier R; Martinon-Ego C; Laharie AM; Marche PN
J Immunol Methods; 2000 May; 239(1-2):95-107. PubMed ID: 10821951
[TBL] [Abstract][Full Text] [Related]
16. Flt-3 ligand, in combination with bovine granulocyte-macrophage colony-stimulating factor and interleukin-4, promotes the growth of bovine bone marrow derived dendritic cells.
Hope JC; Werling D; Collins RA; Mertens B; Howard CJ
Scand J Immunol; 2000 Jan; 51(1):60-6. PubMed ID: 10632977
[TBL] [Abstract][Full Text] [Related]
17. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.
Maraskovsky E; Brasel K; Teepe M; Roux ER; Lyman SD; Shortman K; McKenna HJ
J Exp Med; 1996 Nov; 184(5):1953-62. PubMed ID: 8920882
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-3Ralpha+ myeloid dendritic cells and mast cells develop simultaneously from different bone marrow precursors in cultures with interleukin-3.
Baumeister T; Rössner S; Pech G; de Bruijn MF; Leenen PJ; Schuler G; Lutz MB
J Invest Dermatol; 2003 Aug; 121(2):280-8. PubMed ID: 12880419
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy.
Masurier C; Pioche-Durieu C; Colombo BM; Lacave R; Lemoine FM; Klatzmann D; Guigon M
Immunology; 1999 Apr; 96(4):569-77. PubMed ID: 10233743
[TBL] [Abstract][Full Text] [Related]
20. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
Wells JW; Darling D; Farzaneh F; Galea-Lauri J
Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
